Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Teishima

Showing results (131-140 of 240) with videos related to

Pageof 24
Sort By:
Cancer Science|January 9, 2020
Claspin overexpression is associated with high-grade histology and poor prognosis in renal cell carcinomaGo Kobayashi, Kazuhiro Sentani, Takashi Babasaki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 15, 2024
Adrenalectomy for pheochromocytoma: Surgical outcomes and preoperative risk factors for hemodynamic instabilityKotaro Suzuki, Yasuyoshi Okamura, Yukari Bando, et al.
Cancer Medicine|August 24, 2017
Combination therapy using molecular-targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinomaHiroyuki Kitano, Yasuhiko Kitadai, Jun Teishima, et al.
Oncology Letters|July 12, 2017
A comparison of clinicopathological features and prognosis in prostate cancer between atomic bomb survivors and control patientsKoichi Shoji, Jun Teishima, Tetsutaro Hayashi, et al.
Urologic Oncology|May 21, 2020
Microtubule-associated protein tau (MAPT) promotes bicalutamide resistance and is associated with survival in prostate cancerYohei Sekino, Xiangrui Han, Takashi Babasaki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 3, 2025
Nomogram for Predicting the Survival Outcome of Cabazitaxel Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer: A Multi-Institutional AnalysisKotaro Suzuki, Junichiro Hirata, Hideto Ueki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 24, 2026
The Impact of the Relevant Factors as High-Complexity Tumors in Robot-Assisted Partial NephrectomyJun Teishima, Takuto Hara, Hideto Ueki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 12, 2012
MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinomaShunsuke Shinmei, Naoya Sakamoto, Keisuke Goto, et al.
Biomedicines|August 27, 2021
HOXB5 Overexpression Is Associated with Neuroendocrine Differentiation and Poor Prognosis in Prostate CancerYohei Sekino, Quoc Thang Pham, Kohei Kobatake, et al.
Molecular and Clinical Oncology|April 28, 2020
Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapyJun Teishima, Daiki Murata, Shogo Inoue, et al.
Pageof 24

Showing results (131-140 of 240) with videos related to

Sort By:
Pageof 24
Cancer Science|January 9, 2020
Claspin overexpression is associated with high-grade histology and poor prognosis in renal cell carcinomaGo Kobayashi, Kazuhiro Sentani, Takashi Babasaki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 15, 2024
Adrenalectomy for pheochromocytoma: Surgical outcomes and preoperative risk factors for hemodynamic instabilityKotaro Suzuki, Yasuyoshi Okamura, Yukari Bando, et al.
Cancer Medicine|August 24, 2017
Combination therapy using molecular-targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinomaHiroyuki Kitano, Yasuhiko Kitadai, Jun Teishima, et al.
Oncology Letters|July 12, 2017
A comparison of clinicopathological features and prognosis in prostate cancer between atomic bomb survivors and control patientsKoichi Shoji, Jun Teishima, Tetsutaro Hayashi, et al.
Urologic Oncology|May 21, 2020
Microtubule-associated protein tau (MAPT) promotes bicalutamide resistance and is associated with survival in prostate cancerYohei Sekino, Xiangrui Han, Takashi Babasaki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 3, 2025
Nomogram for Predicting the Survival Outcome of Cabazitaxel Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer: A Multi-Institutional AnalysisKotaro Suzuki, Junichiro Hirata, Hideto Ueki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 24, 2026
The Impact of the Relevant Factors as High-Complexity Tumors in Robot-Assisted Partial NephrectomyJun Teishima, Takuto Hara, Hideto Ueki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 12, 2012
MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinomaShunsuke Shinmei, Naoya Sakamoto, Keisuke Goto, et al.
Biomedicines|August 27, 2021
HOXB5 Overexpression Is Associated with Neuroendocrine Differentiation and Poor Prognosis in Prostate CancerYohei Sekino, Quoc Thang Pham, Kohei Kobatake, et al.
Molecular and Clinical Oncology|April 28, 2020
Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapyJun Teishima, Daiki Murata, Shogo Inoue, et al.
Pageof 24